# Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma

> **NCT06175845** · NA · NOT_YET_RECRUITING · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 130 (estimated)

## Conditions studied

- Cholangiocarcinoma
- Klatskin Tumor
- Bile Duct Cancer
- Liver Cancer

## Interventions

- **PROCEDURE:** Intraductal biliary radiofrequency ablation

## Key facts

- **NCT ID:** NCT06175845
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-02
- **Primary completion:** 2026-01
- **Final completion:** 2026-07
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06175845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06175845, "Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06175845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*